The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Pioneer Agreements and Notice of Results

15 Aug 2018 07:00

RNS Number : 8069X
DeepMatter Group PLC
15 August 2018
 

15 August 2018

DeepMatter Group plc

("DeepMatter", the "Company" or the "Group")

Further Pioneer Agreements Signed and Notice of Interim Results

 

DeepMatter (AIM: DMTR), the AIM listed company focusing on digitizing chemistry, announces that it has now entered into agreements with a total of five organisations for its DigitalGlassware™ Pioneer Programme, which represents the minimum that it planned to initiate during 2018.

 

In addition to the two agreements signed with leading international life science reagent and chemicals manufacturers which were announced by the Company during April 2018, the Company now has signed agreements with three further pioneers, comprising a world-renowned US-headquartered research centre and two universities - one in the UK and one in North America. Entering into agreements with this range of target users reflects the Company's previously described plan to select a range companies and institutions to trial its technology, allowing observation of technology performance in different operating environments and locations worldwide. The Company anticipates entering into further pioneer agreements.

 

The Company's DigitalGlassware™ platform, comprising a powerful and easy-to-use software interface with a unique, low footprint sensor array, collects, stores and processes data generated from chemical experiments and allows access to reproducible chemistry via internet protocols.

 

Under the agreements, each of the Pioneer partners are entitled to multiple instances on the DigitalGlassware™ platform, including hardware and software. Each of the Pioneers is providing manpower and other resources, performing experiments and tests it wishes to perform, in addition to experiments and tests suggested by DeepMatter. The experiments and tests are contributing towards context rich data content, capable of being interrogated with Artificial Intelligence and Machine Learning algorithms, as well as exploring DigitalGlassware's full operating potential.

 

These observations will contribute towards future technology optimisation, prior to wider dissemination to target users. The Pioneer companies will also assess the performance of the DigitalGlassware™ platform, specifically to understand how it can help improve the outcomes of chemical processes, including precision and reproducibility, with an eye to how the technology can help in discovering/enabling new synthetic routes and chemical entities.

 

To date across the Pioneer Programme, which formally started in May 2018, the DigitalGlassware™ platform has been used to collect data from over 5,500 hours of chemistry across over 240 individual experimental runs. 77GiB of data has been collected and structured, comprising nearly 0.9 billion data points from sensors and inputs. These data will be subjected to deep learning methodologies in the quest for unique chemical insights.

 

Notice of unaudited interim results

The Group expects to announce its unaudited interim results for the six months ended 30 June 2018 on 6 September 2018. 

 

 

For further information:

DeepMatter Group plc

www.deepmatter.io

Mark Warne, Chief Executive Officer

T: 0141 465 6871

 

 

Stockdale Securities Limited

 

T: 020 7601 6100

Tom Griffiths/Edward Thomas

 

 

 

 

 

 

DeepMatter Group Plc is a public limited company registered in England and Wales with registered number 5845469 and VAT registered number 225 8481 94. DeepMatter Group plc's shares are admitted to trading on AIM, a market operated by the London Stock Exchange. The registered office is at The Walbrook Building, 25 Walbrook, London, EC4N 8AF. DeepMatter Limited is a private limited company registered in Scotland with registered number SC456741 and VAT registered number 193 1502 21. The registered office is at 38 Queen Street, Glasgow, G1 3DX. This message is intended solely for the addressee and may contain confidential information. If you have received this message in error, please send it back to us, and immediately and permanently delete it. For the avoidance of doubt, unless specifically confirmed in this email as approved final versions, any attached documents are in draft form and should not be referred to, relied upon or quoted for any purpose other than informing us whether any changes are required. Internet communications are not secure or error free and we do not accept any liability for the content of this e-mail. Although e-mails are routinely screened for viruses the sender does not accept responsibility for any damage caused.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGUQPRUPRGQC
Date   Source Headline
28th Aug 20209:05 amRNSSecond Price Monitoring Extn
28th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 20208:54 amRNSHolding(s) in Company
11th Aug 20204:13 pmRNSHolding(s) in Company
6th Aug 202012:30 pmRNSHolding(s) in Company
29th Jul 202012:16 pmRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
23rd Jul 20209:59 amRNSHolding(s) in Company
22nd Jul 20209:05 amRNSSecond Price Monitoring Extn
22nd Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20205:11 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSResults of Placing
13th Jul 20207:00 amRNSPlacing and Subscription to raise £2.1 million
2nd Jul 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20201:39 pmRNSResult of AGM and Directorate Change
4th Jun 20207:00 amRNSDigitalGlassware to Interface with Waters’ UNIFI
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSFinal Results
26th May 20207:00 amRNSNotice of Results and Investor Presentation
11th May 202011:57 amRNSHolding(s) in Company
1st May 20208:21 amRNSHolding(s) in Company
28th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSContract with Cancer Research UK Beatson Institute
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
12th Feb 20207:00 amRNSDeepMatter collaborates with University of Leeds
24th Jan 20207:00 amRNSChange of Adviser
21st Jan 20206:10 pmRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSDeepMatter Appoints Industry Advisors
9th Dec 20194:40 pmRNSSecond Price Monitoring Extn
9th Dec 20194:35 pmRNSPrice Monitoring Extension
9th Dec 201911:05 amRNSSecond Price Monitoring Extn
9th Dec 201911:00 amRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSDeepMatter collaboration with AstraZeneca
19th Sep 20197:00 amRNSInterim Results
12th Aug 20197:00 amRNSLaunch of DigitalGlassware Online Portal
8th Aug 20197:00 amRNSFirst revenues for DigitalGlassware
3rd Jul 20192:55 pmRNSChange of Registered Address
28th Jun 20197:00 amRNSDirectorate Change
21st Jun 201912:34 pmRNSChange of Adviser
3rd Jun 20193:41 pmRNSHolding(s) in Company
22nd May 201911:19 amRNSResult of AGM
12th Apr 20197:01 amRNSBoard Changes & Appointments to Advisory Committee
12th Apr 20197:00 amRNSFinal Results
11th Apr 20195:12 pmRNSHolding(s) in Company
10th Apr 201912:58 pmRNSHolding(s) in Company
4th Apr 20193:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.